Tybriva Capsule
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Ibrutinib (140mg)
Overview Tybriva Capsule
Mantle cell lymphoma and chronic lymphocytic leukemia (CLL) are treated with Tybriva capsules. This medication is also indicated for CLL patients who have undergone at least one prior treatment regimen. Dosage is determined by your physician. Treatment length depends on your response. Regular blood tests monitoring blood cell counts are typically conducted during therapy. A decrease in blood cell count, leading to increased infection risk, is a known side effect. Headache, diarrhea, and nausea are also potential adverse reactions.
Uses of Tybriva Capsule
Mantle cell lymphoma and chronic lymphocytic leukemia are blood cancers.
Major Benefits of Tybriva Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tybriva Capsule. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Tybriva Capsule:
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Tybriva Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tybriva Capsules. These capsules can be administered with or without food, however, consistent timing is recommended.
How Tybriva Capsule works:
Tybriva capsules target Bruton's tyrosine kinase, halting the activity of a faulty protein that triggers cancer cell proliferation. This action inhibits or reduces the growth of cancerous tissue.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Tybriva Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Tybriva capsules is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCAUTION
Mothers who are breastfeeding should exercise caution when taking Tybriva Capsules. Breastfeeding is advised against until the course of treatment concludes and the medication is fully cleared from the maternal system.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Tybriva Capsule.
KidneyCAUTION
Patients with kidney impairment should use Tybriva capsules judiciously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Tybriva capsules; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tybriva Capsule :
NA
Facts to Know About Tybriva Capsule
| Label | Value |
|---|---|
| Chemical Type | Diphenyl ether derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Active Class | BTK inhibitors |
3,018 People bought this recently